During the past decade, Algemeen Ziekenhuis Sint-Augustinus conducted 87 clinical trials. In the 10-year time frame, 87 clinical trials started and 34 clinical trials were completed, i.e. on average, 39.1% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 26 clinical trials were completed. i.e. 72.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Algemeen Ziekenhuis Sint-Augustinus" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 17 trials, followed by "Universitaire Ziekenhuizen KU Leuven" with 8 trials sponsored, "Janssen Research & Development, LLC" with 7 trials sponsored, "Pfizer" with 7 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 7 trials sponsored. Other sponsors include 75 different institutions and companies that sponsored additional 55 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Algemeen Ziekenhuis Sint-Augustinus" #1 collaborator was "GZA Ziekenhuizen Campus Sint-Augustinus" with 6 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 6 trials as a collaborator, "AstraZeneca" with 5 trials as a collaborator, "Cliniques universitaires Saint-Luc- Université Catholique de Louvain" with 3 trials as a collaborator and "University Hospital, Antwerp" with 3 trials as a collaborator. Other collaborators include 87 different institutions and companies that were collaborators in the rest 89 trials.

According to Clinical.Site data, the most researched conditions in "Algemeen Ziekenhuis Sint-Augustinus" are "Breast Cancer" (13 trials), "Metastatic Cancer" (6 trials), "Prostate Cancer" (4 trials), "Urothelial Carcinoma" (4 trials) and "Crohn Disease" (3 trials). Many other conditions were trialed in "Algemeen Ziekenhuis Sint-Augustinus" in a lesser frequency.

Most popular intervention types in "Algemeen Ziekenhuis Sint-Augustinus" are "Drug" (89 trials), "Radiation" (18 trials), "Procedure" (16 trials), "Device" (9 trials) and "Other" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Avelumab" (5 trials), "Carboplatin" (5 trials), "radiation therapy" (4 trials) and "Cisplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Algemeen Ziekenhuis Sint-Augustinus" are 93 trials for "All" genders, 25 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Algemeen Ziekenhuis Sint-Augustinus". undefined are not yet recruiting, 28 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 58 completed trials in Algemeen Ziekenhuis Sint-Augustinus, 1 suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Algemeen Ziekenhuis Sint-Augustinus, 14 "Phase 1" clinical trials were conducted, 43 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 24 trials that are defined as “Not Applicable".

Algemeen Ziekenhuis Sint-Augustinus has several departments that took part in Clinical trials: "Oncologisch Centrum GZA - Location St. Augustinus" - 3 trials, "GZA ziekenhuizen - Campus Sint-Vincentius - Gastro-enterology" - 2 trials